Endoscopic Mucosal Resection Devices Market Size, Share and Growth Outlook, 2026

Endoscopic Mucosal Resection Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Endoscopic Mucosal Resection Devices Market size is forecast to increase from $1.96 Billion in 2026 to $3.99 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034.

The Endoscopic Mucosal Resection Devices market report provides detailed analysis and outlook of Endoscopic Mucosal Resection Devices segments including By Product Category (EMR Snares, Endoscopic Injection Needles & Submucosal Injection Agents, Endoscopic Cap Devices & Distal Attachments, Tissue Retractors, Grasping Forceps, & Closure Clips), By Technology & Methodology (Cap-Assisted EMR, Ligation-Assisted, Conventional Underwater EMR), By Disease Indication (Colorectal Cancer & Precancerous Polyps, Barrett’s Esophagus & Esophageal Carcinoma, Early-Stage Stomach, Duodenal & Small Bowel Lesions), By End-User (Hospitals & Academic Medical Centers, Ambulatory Surgical Centers, Outpatient Endoscopy Suites) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Endoscopic Mucosal Resection Devices Industry Overview

Advanced EMR Device Innovations Supporting Gastrointestinal Lesion Resection

The endoscopic mucosal resection (EMR) devices industry is experiencing significant technological advancement as healthcare providers increasingly adopt minimally invasive solutions for the removal of gastrointestinal polyps and early-stage neoplastic lesions. Manufacturers are focusing on improving resection precision, procedural efficiency, and post-procedural safety through specialized endoscopic consumables and defect-closure technologies. The growing utilization of endoscopic interventions in outpatient and ambulatory surgical center environments continues to strengthen demand for advanced EMR snares, electrosurgical accessories, injection systems, and tissue management devices.

Product Development Enhancing Precision and Procedural Control

Boston Scientific Corporation expanded its interventional endoscopy portfolio through the launch of a dedicated range of cold and hot endoscopic mucosal resection snares. These devices incorporate an optimized thin-wire braided architecture specifically engineered to maximize tissue contact during resection procedures. The enhanced design provides distinct tactile feedback, enabling gastroenterologists to perform lift-and-cut resections of flat and sessile gastrointestinal polyps with greater procedural control. The availability of both cold and hot EMR snare configurations supports diverse clinical approaches across different lesion types and anatomical locations throughout the gastrointestinal tract.

Defect Closure Technologies Improving Post-EMR Outcomes

Clinical evidence continues to reinforce the importance of post-resection defect management within the endoscopic mucosal resection devices market. A comprehensive assessment published in the World Journal of Gastrointestinal Endoscopy evaluated modern through-the-scope and over-the-scope clipping technologies used after advanced endoscopic resections. The findings demonstrated that proactive closure of endoscopic defects through automated mechanical clipping systems significantly reduces delayed post-procedural bleeding and secondary perforation risks, particularly in high-tension duodenal and right-colon EMR sites. These findings are driving broader adoption of integrated closure systems alongside EMR procedures.

Distribution Expansion Supporting High-Volume Endoscopy Centers

Supply chain expansion remains a critical industry trend. Micro-Tech (Nanjing) Co., Ltd. strengthened its distribution footprint across multiple Asia-Pacific healthcare networks to improve access to single-use endoscopy consumables. The initiative focuses on maintaining consistent inventories of electrosurgical knives, injection needles, and dual-action snares used in mucosal lifting and resection procedures. By ensuring uninterrupted product availability, outpatient ambulatory surgical centers and hospital endoscopy units can support higher procedural volumes while maintaining standardized EMR workflows and operational efficiency.

Endoscopic Mucosal Resection Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Endoscopic Mucosal Resection Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Olympus Corporation, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, FUJIFILM Holdings Corporation, CONMED Corporation, STERIS plc, Micro-Tech Endoscopy, Erbe Elektromedizin GmbH, HOYA Corporation (PENTAX Medical). The Endoscopic Mucosal Resection Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Endoscopic Mucosal Resection Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Endoscopic Mucosal Resection Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Endoscopic Mucosal Resection Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Endoscopic Mucosal Resection Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Endoscopic Mucosal Resection Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Endoscopic Mucosal Resection Devices industry include- Olympus Corporation, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, FUJIFILM Holdings Corporation, CONMED Corporation, STERIS plc, Micro-Tech Endoscopy, Erbe Elektromedizin GmbH, HOYA Corporation (PENTAX Medical). The Endoscopic Mucosal Resection Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Endoscopic Mucosal Resection Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Endoscopic Mucosal Resection Devices market remains one of the strongest-performing segments in the country.
The US Endoscopic Mucosal Resection Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Endoscopic Mucosal Resection Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Endoscopic Mucosal Resection Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Endoscopic Mucosal Resection Devices markets

Canada's strong Endoscopic Mucosal Resection Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Endoscopic Mucosal Resection Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Endoscopic Mucosal Resection Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Endoscopic Mucosal Resection Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Endoscopic Mucosal Resection Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Endoscopic Mucosal Resection Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Endoscopic Mucosal Resection Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Endoscopic Mucosal Resection Devices sales through 2034

France Endoscopic Mucosal Resection Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Endoscopic Mucosal Resection Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Endoscopic Mucosal Resection Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Endoscopic Mucosal Resection Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Endoscopic Mucosal Resection Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Endoscopic Mucosal Resection Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Endoscopic Mucosal Resection Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Endoscopic Mucosal Resection Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Endoscopic Mucosal Resection Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Endoscopic Mucosal Resection Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Endoscopic Mucosal Resection Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Endoscopic Mucosal Resection Devices Market Segmentation

By Product Category
EMR Snares
Endoscopic Injection Needles & Submucosal Injection Agents
Endoscopic Cap Devices & Distal Attachments
Tissue Retractors, Grasping Forceps, & Closure Clips
By Technology & Methodology
Cap-Assisted EMR
Ligation-Assisted
Conventional Underwater EMR
By Disease Indication
Colorectal Cancer & Precancerous Polyps
Barrett’s Esophagus & Esophageal Carcinoma
Early-Stage Stomach
Duodenal & Small Bowel Lesions
By End-User
Hospitals & Academic Medical Centers
Ambulatory Surgical Centers
Outpatient Endoscopy Suites

Top Companies in Endoscopic Mucosal Resection Devices Industry

Olympus Corporation
Boston Scientific Corporation
Cook Medical LLC
Medtronic plc
FUJIFILM Holdings Corporation
CONMED Corporation
STERIS plc
Micro-Tech Endoscopy
Erbe Elektromedizin GmbH
HOYA Corporation (PENTAX Medical)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025